FDA Investigator

Ekaterina Allen

Latest inspection on record: Reykjavik, Iceland, July 2025 · records back to 2019

Human DrugsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 7 inspections across 7 sites are on record.
  • 4 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-07-04.

At a glance

Inspections

7

Sites

7

Observations

4

Career since

Aug 2019

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Alvotech HF4 Jul 2025Human DrugsOn file
Patheon Italia S.p.A18 Feb 2025Human DrugsOn file
Patheon Manufacturing Services LLC30 Aug 2024Human DrugsOn file
Catalent Anagni SRL16 Jul 2024Human DrugsOn file
AstraZeneca Pharmaceuticals LP31 May 2024Human DrugsView 483 →

Sites inspected

Alvotech HFReykjavik, Iceland1 insp.
Patheon Italia S.p.AFerentino, Italy1 insp.
Patheon Manufacturing Services LLCRidgefield, United States1 insp.
Catalent Anagni SRLAnagni, Italy1 insp.
AstraZeneca Pharmaceuticals LPGaithersburg, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Zhong Li2 shared
Leiyun W Boone1 shared
Della Shin1 shared
Ruo H Xu1 shared

Full investigator report

Get the verbatim findings behind Ekaterina Allen's 4 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site